
Black Patients Still Underrepresented in Trials for New Drug Approvals in 2015
Black patients remain underrepresented in drug trials despite FDA's 2015 diversity plan. Explore strategies to enhance trial inclusivity.












By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.
Are you a healthcare professional? Register with us today!